Russell Investments Group, Ltd.

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA

Position in ORIC

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,080,205

-$2,252,751 QoQ

Shares Held

99,742

-62.1% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 179 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 76% Shared 0% None 24%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. ORIC ranks #119 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,080,205	99,742	-62.1%	Shares	Defined	2026-08-06
2026-03-31	$3,332,956	263,059	+27.1%	Shares	Defined	2026-05-08
2025-12-31	$1,693,561	207,037	+4062.4%	Shares	Defined	2026-02-17
2025-09-30	$59,688	4,974	+350.1%	Shares	Defined	2025-11-13
2024-06-30	$7,812	1,105	+3846.4%	Shares	Defined	2024-08-08
2023-09-30	$169	28	-97.2%	Shares	Defined	2023-11-13
2022-03-31	$5,361	1,004	0.0%	Shares	Defined	2022-05-05
2021-12-31	$14,758	1,004	0.0%	Shares	Defined	2022-01-21
2021-09-30	$20,993	1,004	—	Shares	Defined	2021-11-08
No filing history on record for this holder in this stock.